Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen for pain during pulp therapy of mandibular primary molars
IRCT20161029030552N3Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ibuprofen in irreversible pulpitis, sponsored by Shiraz University of Medical Sciences. Started Sep 2017; status: completed.
02
Drugs
ibuprofen
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20161029030552N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161029030552N3.